Abstract
Criticism of HL ruling that patent for hepatitis B virus antigen was invalid because claim was too broad, insufficiently inventive and unsupported by disclosure.
Original language | English |
---|---|
Pages (from-to) | 301-310 |
Number of pages | 10 |
Journal | International Journal of Biosciences and the Law |
Volume | 1 |
Issue number | 3 |
Publication status | Published - 1 Jan 1997 |
Externally published | Yes |